CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Statement [Abstract]
Net sales	$ 1,674	$ 801	$ 4,440	$ 1,629
Cost of goods sold (exclusive of depreciation and amortization shown separately below)	(5,873)	(2,063)	(17,152)	(4,708)
Selling, general, and administrative expenses (inclusive of research and development costs)	(10,766)	(7,432)	(45,778)	(17,666)
Depreciation and amortization	(3,517)	(772)	(9,033)	(1,547)
Impairment loss	(2,252)	(1,610)	(66,504)	(1,610)
Operating loss	(20,734)	(11,076)	(134,027)	(23,902)
Interest (expense) income, net	(677)	(138)	(1,494)	28
Change in fair value of earn-out and warrant liabilities	19,777	0	37,027	0
Other income (expense)	95	(364)	742	(284)
Loss from operations before income tax	(1,539)	(11,578)	(97,752)	(24,158)
Income tax benefit	485	0	1,773	0
Loss before equity in net loss of affiliate	(1,054)	(11,578)	(95,979)	(24,158)
Equity in net loss of affiliate	25	0	73	0
Net loss	(1,079)	(11,578)	(96,052)	(24,158)
Currency translation adjustments	(4,134)	0	(14,655)	0
Total comprehensive loss	$ (5,213)	$ (11,578)	$ (110,707)	$ (24,158)
Net loss per share - basic (in dollars per share)	$ (0.05)	$ (0.76)	$ (4.64)	$ (1.60)
Net loss per share - diluted (in dollars per share)	$ (0.05)	$ (0.76)	$ (4.64)	$ (1.60)
Weighted average common shares outstanding - basic (in shares)	23,688,000	15,282,000	20,686,000	15,129,000
Weighted average common shares outstanding - diluted (in shares)	23,688,000	15,282,000	20,686,000	15,129,000